Two Sigma Advisers’s AC Immune ACIU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $58.5K | Buy |
28,810
+5,200
| +22% | +$10.6K | ﹤0.01% | 2247 |
|
|
2025
Q1 | $44.2K | Buy |
23,610
+10,200
| +76% | +$19.1K | ﹤0.01% | 2327 |
|
|
2024
Q4 | $36.2K | Buy |
+13,410
| New | +$36.2K | ﹤0.01% | 2305 |
|
|
2022
Q2 | – | Sell |
-23,644
| Closed | -$95K | – | 2625 |
|
|
2022
Q1 | $95K | Sell |
23,644
-70,200
| -75% | -$282K | ﹤0.01% | 2513 |
|
|
2021
Q4 | $465K | Sell |
93,844
-18,900
| -17% | -$93.7K | ﹤0.01% | 1946 |
|
|
2021
Q3 | $757K | Buy |
112,744
+21,600
| +24% | +$145K | ﹤0.01% | 1740 |
|
|
2021
Q2 | $723K | Buy |
91,144
+76,200
| +510% | +$604K | ﹤0.01% | 1774 |
|
|
2021
Q1 | $114K | Buy |
+14,944
| New | +$114K | ﹤0.01% | 2432 |
|
|
2020
Q3 | – | Sell |
-14,944
| Closed | -$101K | – | 2376 |
|
|
2020
Q2 | $101K | Buy |
14,944
+3,244
| +28% | +$21.9K | ﹤0.01% | 2356 |
|
|
2020
Q1 | $81K | Buy |
+11,700
| New | +$81K | ﹤0.01% | 2325 |
|